An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis
Clinical trial NCT03229252 · COMPLETED
Trial details
- NCT number
- NCT03229252
- Sponsor
- Spyryx Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2019-06-20
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.